Norigon (Butamirate Citrate)

Butamirate citrate, the active ingredient in Norigon, is a cough suppressant presented as an oral tablet for systemic use. It is indicated for the relief of dry, non‑productive coughs in adults and adolescents and provides symptomatic control without affecting normal respiratory function.

GNH USA supplies Norigon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and other markets. We partner with accredited manufacturers to maintain product integrity throughout the supply chain.

Butamirate citrate is used as an antitussive agent to suppress cough reflexes in the respiratory tract. - Dry cough: reduces frequency and intensity of coughing episodes. - Non‑productive cough: provides symptomatic relief without producing sputum. - Irritative cough due to throat irritation: alleviates cough caused by mild upper‑respiratory irritation. - Cough during night: helps maintain uninterrupted sleep. - Cough after exposure to dry air: eases discomfort.

Butamirate citrate may cause a range of adverse reactions, most of which are mild and transient. Common Side Effects: - Drowsiness: mild sedation or feeling of tiredness. - Nausea: occasional upset stomach. - Dry mouth: reduced salivation. - Dizziness: light‑headed sensation. Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Anaphylaxis: life‑threatening systemic allergic response.

When using Norigon, several precautions should be observed to ensure safe and effective therapy. - Assess patient history: confirm absence of hypersensitivity to butamirate or similar agents. - Use in pregnancy: avoid unless clearly needed, as safety data are limited. - Use in lactation: caution advised; limited information on excretion in breast milk. - Concomitant CNS depressants: monitor for additive sedation. - Renal impairment: dose adjustment may be required; monitor renal function. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Butamirate citrate can interact with other medicines, influencing its efficacy or safety profile. Major Interactions (Avoid): - Alcohol: may enhance central nervous system depression and drowsiness. - Opioid antitussives (e.g., codeine): combined use can increase risk of respiratory depression. Moderate Interactions (Monitor Closely): - Sedative antihistamines: may potentiate drowsiness. - CNS depressants (benzodiazepines, barbiturates): monitor for excessive sedation. - Anticholinergic drugs: may worsen dry mouth. - Antihypertensive agents: possible additive hypotensive effect.